Abstract. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most frequent cancer worldwide. SCC is the most common malignant tumor of the oral cavity with over 35,000 cases and 8,000 deaths reported in the United States each year. Previous case studies have reported increased incidence of HNSCC in patients on immunosuppressive therapy for organ transplantation. The results of these studies indicate that effective immune surveillance is important for preventing emergence of HNSCC. HNSCC may also inhibit immune response to tumor cells, which may be responsible for progression. We previously reported induction of metastatic HNSCC in p53 null mutant mice. Despite induction with the potent carcinogen dimethylbenzanthracene, each mouse developed only 1-2 primary tumors with a relatively long induction period of 22 weeks. We hypothesized that immune surveillance might eliminate early tumor cells resulting in the relatively small number of primary tumors and long induction time. To test this hypothesis we performed the induction protocol in nude mice which have defective T lymphocyte function. Decreased T lymphocyte function resulted in reduced tumor latency and increased tumor formation. Immunohistochemical studies showed that expression of cell cycle regulatory proteins is similar in mouse and human HNSCC. However, distinct differences exist between primary and metastatic tumors from nude and wild-type mice. We also determined that lymphocytes react to metastatic tumor cells by upregulating immunoglobin gene expression but are prone to apoptosis via decreased expression of survival factors and upregulation of cell death genes.
Introduction
Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most frequent cancer worldwide (1). HNSCC is a major cause of morbidity and mortality in developing nations, comprising up to 50% of all malignant tumors. SCC is the most common malignant tumor of the oral cavity with over 35,000 cases and 8,000 deaths reported in the United States each year (2) . Tobacco carcinogens are the primary etiologic agents of the disease with age and genetic background as contributory factors. The overall 5-year survival rate is low among the major cancers and has not declined significantly in recent years.
Previous case studies have reported increased incidence of HNSCC in patients on immunosuppressive therapy for organ transplantation (3) (4) (5) (6) (7) . Induction of HNSCC was second to that of liver cancer in patients with bone marrow transplant (8) . The results of these studies indicate that effective immune surveillance is important for preventing emergence of HNSCC. HNSCC may also inhibit immune response to tumor cells, which may be responsible for progression (9) . It has been proposed that immune surveillance consists of three phases: elimination, equilibrium, and escape (10, 11) . Tumor elimination is the goal of immunosurveillance, but during equilibrium and escape the interactions between the immune system and tumor cells may result in development of cells which can gradually inactivate or kill immune effector cells. Later stages of tumor development may include cells which are less immunogenic. Natural killer and cytotoxic T lymphocytes which have crucial effector functions in immune defense against tumor cells are inactivated in HNSCC (12, 13) . Regression of tumor grafts is characterized by NK and cytotoxic T lymphocyte attack, and patients with metastatic HNSCC have low NK and cytotoxic T lymphocyte activity (14, 15) . Spontaneous apoptosis of circulating T lymphocyte populations in patients with HNSCC is an indicator of diminished immune function (16) . Cytokine induced stimulation of the immune system and transfer of effector cells have not been effective in head and neck cancer therapy (17, 18) . Tumor infiltrating lymphocytes are not cytotoxic to autologous tumor cells and exhibit reduced clonogenicity (19) . Human HNSCC have been shown to induce minimal cell mediated anti-tumor immune responses (20) . Diminished numbers of cytotoxic T lymphocytes correlated with reduced survival in cancer patients (21) . A variety of cellular defects such as signaling abnormalities, spontaneous apoptosis, and reduced proliferation have been reported in natural killer, T lymphocyte, and dendritic cells in HNSCC patients (16, 22) . The results of these studies indicate that cell mediated immune responses are critically important in tumor initiation and progression.
We previously reported induction of metastatic HNSCC in p53 null mutant mice (23) . These tumors ranged from well to poorly differentiated histopathology and showed many molecular features of human HNSCC. These tumors progressed rapidly which resulted in euthanasia criteria being met in 13 weeks. Despite induction with the potent carcinogen dimethylbenzanthracene, each mouse developed only 1-2 primary tumors with a relatively long induction period of 22 weeks. We hypothesized that immune surveillance might eliminate early tumor cells resulting in the relatively small number of primary tumors and long induction time. To test this hypothesis we performed the induction protocol in nude mice which have defective T lymphocyte function. Our results show that defective T lymphocyte function reduces tumor latency period and significantly increases tumor number. Global gene expression profiling demonstrated important differences between HNSCC induced in nude and wild-type mice. We also profiled gene expression in lymphocytes exposed to metastatic tumor cells in vivo. Tumor cell exposed lymphocytes upregulate immunoglobin gene expression but are prone to apoptosis via decreased expression of survival factors and upregulation of cell death genes. The results of our study indicate that T lymphocyte function is an important regulator of tumor development in HNSCC.
Materials and methods
Mouse procedures. This study was approved by the Institutional Animal Care and Use Committee before any experiments were performed. The Foxn1 mutant (nude) mouse strain was purchased from The Jackson Laboratory (Bar Harbor, ME). C57Bl6J mice were used as control animals. Mice were housed in approved environmentally controlled facilities on 12-h light-dark cycles with unlimited access to food and water. Twenty male and female 1-month old nude and wild-type mice were dosed orally twice weekly using 25 μl dimethylbenzanthracene (DMBA) dissolved in 20 μl ethanol. The time course and number of tumors were recorded for each animal. Mice were euthanized when any institutional criterion for experimental neoplasia in rodents was met. Complete necropsies were performed on each mouse. A portion of each tumor specimen was flash frozen in liquid nitrogen or fixed in 4% buffered formaldehyde for 16 h at room temperature.
Histopathology and immunohistochemistry. Tumor tissue was dehydrated in an ethanol series, cleared in xylene, and embedded in paraffin. Five micrometer sections were prepared and mounted on poly-L-lysine coated slides. Representative sections were stained with hematoxylin and eosin and histologically evaluated by a pathologist. Immunohistochemical analysis was performed using a commercially available kit (Invitrogen, Carlsbad, CA). Sections were incubated at 60˚C for 30 min and deparaffinized in xylene. Endogenous peroxidase activity was quenched by incubation in a 9:1 methanol/30% hydrogen peroxide solution for 10 min at room temperature. Sections were rehydrated in PBS (pH 7.4) for 10 min at room temperature. Sections were blocked with 10% normal serum for 10 min at room temperature followed by incubation with anti-EGFR, cyclin A, cyclin B, cyclin D, cyclin E, p16, c-myc, HGF, TGF·, c-met, and PCNA antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for 16 h at room temperature.
After three washes in PBS, the sections were incubated with secondary antibody conjugated to biotin for 10 min at room temperature. After additional washes in PBS, the sections were incubated with streptavidin conjugated horseradish peroxidase for 10 min at room temperature. Following final washes in PBS, antigen-antibody complexes were detected by incubation with hydrogen peroxide substrate solution containing aminoethylcarbazole chromogen reagent. Slides were rinsed in distilled water, coverslipped using aqueous mounting medium, and allowed to dry at room temperature. The relative intensities of the completed immunohistochemical reactions were evaluated using light microscopy by independent trained observers who were unaware of the mouse genotypes. A scale of 0-3 was used to score relative intensity, with 0 corresponding to no detectable immunoreactivity and 1, 2, and 3 equivalent to low, moderate, and high expression respectively. Non-parametric data was analyzed by Fisher exact test.
RNA extraction and gene expression profiling. Total RNA was extracted from microdissected primary and metastatic tumor tissue using a commercially available kit (RNasy, Qiagen, Valencia, CA). Individually matched well differentiated primary and metastatic tumor tissue was used in microarray analysis. Three independent samples from each group were used in gene expression analysis. The integrity of rRNA bands was confirmed by Northern gel electrophoresis. Total RNA (10 μg) with spike in controls was reverse transcribed using a T7-oligo(dT) promoter primer in the first strand cDNA synthesis reaction. Following RNase H mediated second strand synthesis, the double stranded cDNA was purified and served as template in the subsequent in vitro transcription reaction. The in vitro transcription reaction was carried out in the presence of T7 RNA polymerase and a biotinylated nucleotide analogue/ribonucleotide mix for complementary RNA amplification and biotin labeling. The biotinylated complementary RNA targets were then purified, fragmented, and hybridized to Affymetrix GeneChip Expression arrays (Santa Clara, CA). The murine genome 430 2.0 microarray was used to interrogate 39,000 possible transcripts in each sample. After washing, hybridization signals were detected using streptavidin conjugated phycoerythrin. Affymetrix GCOS software was used to generate raw gene expression scores and normalized to the relative hybridization signal from each experiment. All gene expression scores were set to a minimum value of 2 times background determined by GCOS software in order to minimize noise associated with less robust measurements of rare transcripts. Normalized gene expression data was imported into dChip sotware for hierarchical clustering analysis using the average linkage algorithm. Raw data was analyzed for quality control and the significance of differential gene expression determined by t-test (p<0.05) and ratio analysis (>2-fold).
Results
We used the chemical carcinogenesis protocol described in Materials and methods to induce head and neck cancer in the nude mouse. As shown in Fig. 1 , nude mice developed tumors by 14 weeks induction on average compared to 22 weeks for wild-type animals (p<0.0002). This latency period was 4 weeks shorter than tumor formation in p53+/-mice as previously reported (23) . There also was a dramatic increase in the number of tumors in nude mice ( Fig. 2A) . Nude mice developed 5.1 tumors per mouse while wild-type animals had only 1.4 lesions/mouse (p<10 -12 ). There were no significant differences in primary tumor growth rates or number of metastatic lymph nodes in nude and wild-type mice ( Fig. 2B and C). These results indicate that decreased T lymphocyte function results in reduced tumor latency and increased tumor formation.
We examined the histopathology of head and neck tumors in both nude and wild-type mice. In nude mice, primary tumors were well differentiated SCC which developed primarily on labial and buccal mucosa (Fig. 3A) . In wild-type mice, 60% of SCC were well differentiated, 30% were moderately differentiated, and 10% were poorly differentiated as previously reported (23) . We examined expression of several cell cycle regulatory proteins in tissue sections of primary tumors by immunohistochemistry. We previously demonstrated correlations between expression of these proteins in human HNSCC (24) . Epidermal growth factor receptor, PCNA, cyclin A, cyclin B, cyclin D, cyclin E, HGF, c-met, and TGF· were overexpressed in 40-50% of SCC in nude mice (Fig. 3B-H and J-L). c-myc was overexpressed in 25% of primary SCC (Fig. 3I) . These percentages were similar to those observed in wild-type mice. These results indicate that expression of cell cycle regulatory proteins is similar in SCC in nude and wild-type mice.
The average number of cervical lymph nodes containing metastatic tumor cells was 4.1 per mouse, which was not significantly different between nude and wild-type mice. At necropsy, there was no evidence of tumor extension through the lymph node capsule or distant metastasis to any organ. Metastatic tumor in cervical lymph nodes were uniformly moderately differentiated SCC in both nude and wild-type mice (Fig. 3M ). These tumors showed decreased stratification and keratinization, loss of intercellular junctions, increased nuclear/cytoplasmic ratio, nuclear pleiomorphism, and occasional mitotic figures. We examined expression of cell cycle regulatory proteins in metastatic tumors in nude and wild-type mice. PCNA was overexpressed in 50% of metastatic tumors in nude mice compared to 10% in wild-type animals ( Fig. 3N) . Cyclins B and D were overexpressed in 13% of metastatic tumors in nude mice, and c-met was overexpressed in 25% of metastatic tumors in these animals which was similar to percentages observed in wild-type animals (data not shown). These results indicate that distinct differences exist between primary and metastatic tumors in the mouse model.
To characterize differences in gene expression between primary well differentiated SCC in nude and wild-type mice, we performed global gene expression profiling by microarray analysis. As shown in Table I , proteins initially characterized in salivary gland differentiation were upregulated in squamous cell carcinoma from nude mice (demilune cell and parotid protein, 56.1-fold; cysteine-rich secretory protein 1, 43.7-fold; submaxillary gland androgen regulated protein 1, 35.1-fold). A number of the forkhead family of transcription factors were differentially regulated in SCC from nude mice (forkhead box A1, 33.8-fold; forkhead box G1, 7.6-fold; forkhead box C1, 5.7-fold; forkhead box P4, -6.3-fold). Keratins found in simple epithelia were upregulated in SCC in nude mice (keratin 19, 26.6-fold; keratin 8, 19.8-fold; keratin 18, 15.9-fold). Genes involved in terminal differentiation were downregulated in SCC from nude mice (transglutaminase 3, -26.9-fold; desmoglein 1ß, -7.8-fold; corneodesmosin, -5.4-fold; keratin complex 1, acidic, gene 5, -5.1-fold). Inhibitory growth factor pathways were downregulated in SCC from nude mice (transforming growth factor ß receptor III, -9.3-fold; bone morphogenic protein receptor, type II, -6.8-fold; transforming growth factor ß2, -5.6-fold). The growth promoting epidermal growth factor receptor also was downregulated by 5.1-fold. Genes involved in epigenetic regulation were downregulated [Jumonji, AT rich interactive domain 2, -7.6-fold; jumonji, AT rich interactive domain 1C (Rbp2 like), -7.1-fold; p300/ CBP-associated factor, -6.9-fold; histone deacetylase 8, -6.2-fold; CREB binding protein, -5.3-fold]. Genes involved in embryonic development were differentially regulated in SCC from nude mice (SRY-box containing gene 2, 18.2-fold; homeobox B3, 6.6-fold; SRY-box containing gene 9, 6.1-fold; distal-less homeobox 5, -5.3-fold). These results suggest that differentiation of HNSCC from nude mice is altered compared to those arising in wild-type mice. Table I . Gene expression changes between primary SCC in wild-type and nude mice (831 genes). ----------------------------------------------------------------------------------------------------- We also examined gene expression changes between metastatic SCC in wild-type and nude mice. As shown in Table II , 2144 differentially expressed genes were identified between metastatic SCC in wild-type and nude mice. A number of kinases were upregulated in metastatic SCC from nude mice (phosphatidylinositol-4-phosphate 5-kinase, 25.9-fold; nemo like kinase, 21.8-fold; casein kinase 1, 10.5-fold). Growth factors and receptors were upregulated in SCC from nude mice (desert hedgehog, 7.4-fold; nerve growth factor receptor, 6.9-fold; transforming growth factor ß2, 6.4-fold; fibroblast growth factor 4, 6.2-fold; hepatoma derived growth factor, 5.3-fold; frizzled homolog 3, 5.2-fold). Telomere associated proteins were upregulated in SCC from nude mice (telomeric repeat binding factor 2, 9.2-fold; tankyrase, 6.0-fold). Transcription factors were also upregulated in metastatic SCC from nude mice (CCAAT/enhancer binding protein ‰, 9.0-fold; signal transducer and activator of transcription 3, 5.5-fold; forkhead box F1a, 5.5-fold; transformation related protein 63, 5.4-fold). Histone demethylases were differentially regulated in metastatic SCC from nude mice (Jumonji domain containing 1C, 7.4-fold; Jumonji domain containing 3, 5.8-fold; Jumonji, AT rich interactive domain 1A, -9.0-fold; Jumonji, AT rich interactive domain 1C, -10.3-fold). Certain growth factors and receptors were downregulated in metastatic SCC from nude mice (Jagged 1, -5.2-fold; ‰ like 3, -5.8-fold; transforming growth factor receptor ß1, -6.4-fold; wingless related MMTV integration site 10a, -6.9-fold). Tumor suppressor expression was inhibited in metastatic SCC from nude mice (BRCA1 associated protein, -5.1-fold; retinoblastoma binding protein 6, -7.0-fold; large tumor suppressor 2, -12.7-fold). Markers of epithelial differentiation were downregulated in metastatic SCC from nude mice (suprabasin, -6.6-fold; mucin 10, -7.4-fold; desmoplakin, -8.1-fold). Cell cycle regulatory genes were inhibited in metastatic SCC from nude mice (cyclin D2, -7.5-fold; cyclin dependent kinase inhibitor 1B, -14.0-fold). Specific transcription factors also were downregulated in metastatic SCC from nude mice (retinoid X receptor Á, -5.2-fold; forkhead box Q1, -5.6-fold; Jun proto-oncogene related gene D1, -6.1-fold; Vav3 oncogene, -10.4-fold; lymphoid enhancer factor 1, -12.7-fold; myeloblastosis oncogene, -57.8-fold). These gene expression changes suggest that metastatic SCC from nude mice may be more biologically aggressive than their counterparts in wild-type mice.
In previously published study, we examined differential gene expression between primary and metastatic tumors in wild-type mice (23) . In the present study, we examined gene expression differences between primary and metastatic tumors in nude mice. As shown in Table III , chemokine ligands and receptors were upregulated in metastatic SCC compared to primary tumors (Cxcl9, 37.5-fold; Ccl19, 27.2-fold; Cxcl13, 17.0-fold; Ccl8, 13.5-fold; Ccl5, 11.2-fold; Cxcl10, 7.6-fold; Ccr6, 5.7-fold; Cxcl12, 5.0-fold). Signal transduction genes also were upregulated in metastatic SCC (Ras related C3 botulinum substrate 2, 20.3-fold; signal transducer and activator of transcription 1, 12.6-fold; growth factor receptor bound protein 2, 6.3-fold; c-src tyrosine kinase, 5.8-fold). Growth factors and receptors were downregulated in metastatic SCC compared to primary tumors in nude mice (heparin binding EGF like growth factor, -5.0-fold; epidermal growth factor, -5.1-fold; smoothened homolog, -5.3-fold; v-erb-b2 erythroblastic leukemia viral oncogene, -6.5-fold; bone morphogenetic protein 1, -7.0-fold; amphiregulin, -7.8-fold; growth hormone receptor, -8.9-fold; Jagged 1, -10.1-fold; connective tissue growth factor, -24.8-fold). Epithelial differentiation markers were downregulated in metastatic SCC (vitamin D receptor, -6.7-fold; loricrin, -13.1-fold; keratin 8, -15.8-fold; desmoglein 3, -20.0-fold; keratin 18, -21.7-fold; keratin 16, -23.0-fold; suprabasin, -39.1-fold; desmoplakin, -45.0-fold; keratin 10, -50.5-fold; keratin 6a, -90.5-fold; keratin 5, -94.6-fold; small proline rich protein 2A, -110.9-fold; keratin 14, -123.1-fold). Peptidase inhibitor gene expression was down-regulated in metastatic SCC (serpin E1, -5.4-fold; serine peptidase inhibitor 5, -6.7-fold; tissue inhibitor of metalloproteinase 1, -12.0-fold). These gene expression changes are consistent with metastatic phenotype in the nude mouse model of SCC.
We wondered how lymphocytes in cervical lymph nodes responded to metastatic tumor cells. We performed differential gene expression on wild-type lymphocytes from non-tumor bearing mice and those in contact with metastatic tumor cells in lymph nodes. As shown in Table IV . A number of other lymphocyte genes were upregulated in tumor cell exposed lymphocytes (lymphocyte antigen 9, 17.8-fold; pre-B lymphocyte gene 1, 11.3-fold; lymphocyte enhancer binding factor 1, 9.6-fold). Toll like receptor signaling was upregulated in tumor cell exposed lymphocytes (toll like receptor 4, 9.8-fold; toll like receptor 12, 6.3-fold; toll like receptor adaptor molecule 1, 6.2-fold; toll interleukin 1 receptor domain adaptor protein, 5.2-fold). Cell death genes were upregulated in tumor cell exposed lymphocytes (BH3 interacting domain death agonist, 11.2-fold; programmed cell death 1, 10.3-fold; caspase 7, 7.0-fold; caspase recruitment domain 4, 5.7-fold). A number of lymphocyte survival factors were downregulated in tumor cell exposed lymphocytes (BCL2 like 12, -20.2-fold; myeloproliferative leukemia virus oncogene, -19.1-fold; plasmacytoma expressed transcript 2, -14.2-fold; B-cell CLL/lymphoma 7A, -14.1-fold; B cell leukemia/lymphoma 11B, -11.3-fold; early B cell factor 3, -8.3-fold; pre B cell leukemia transcription factor 4, -8.2-fold; B cell translocation gene 4, -7.1-fold; pre B cell leukemia transcription factor 1, -6.1-fold; T cell lymphoma invasion and metastasis 2, -5.9-fold; inhibitor of Bruton agammaglobulinemia tyrosine kinase, -5.8-fold; B cell CLL/ lymphoma 9 like, -5.4-fold; B cell leukemia/lymphoma 2 related protein A1a, -5.1-fold). These results indicate that lymphocytes react to metastatic tumor cells by upregulating immunoglobin gene expression but are prone to apoptosis via decreased expression of survival factors and upregulation of cell death genes. Table II . Gene expression changes between metastatic SCC in wild-type and nude mice (2144 genes). ---------------------------------------------------------------------------------------------------- -Table III . Gene expression changes between primary and metastatic SCC in nude mice (1205 genes). --------------------------------------------------------------------------------------------------- -Table IV . Gene expression changes between normal node and metastatic SCC node lymphocytes (840 genes). (28) . Vaccinated mice remained tumor-free but naïve mice developed a progressively growing tumor. Despite specific recognition by T lymphocytes, tumors did not lose immunogenicity and were rejected when transplanted to immunocompetent recipients. Tumor induced tolerance was associated with expansion of non-functional T lymphocytes. A variety of tumor derived factors contribute to immunosuppressive networks including VEGF, interleukin 10, TGFß, prostaglandin E, and Fas ligand (reviewed in ref. 29) . These factors may be active at distant sites, thereby promoting invasion and metastasis. VEGF recruits bone marrow cells to become immature dendritic cells and macrophages. These immature cells may suppress roving dendritic cells and T lymphocytes. Soluble Fas ligand may help tumor cells escape lysis by cytotoxic T lymphocytes and natural killer cells by inducing apoptosis in the immune cells. In a mouse chemical carcinogenesis model, it was demonstrated that equilibrium was mechanistically distinguishable from elimination and escape (30) . Neoplastic cells in this model were transformed but proliferated poorly in vivo. These cells were unedited in equilibrium but are edited when they escape immune control and become tumors. These results highlight the complex interplay between cancer cells and the immune system. We determined that the largest class of upregulated genes in lymphocytes exposed to metastatic HNSCC was immunoglobulin genes. The antigens arising during the course of the disease may derive from somatic mutations in normal gene products, tumor specific antigens shared among patients with a particular type of cancer, normal tissue specific gene products, and normal proteins predominantly expressed by tumors (31) (32) (33) (34) . However, lymphocytes exposed to metastatic tumor cells were prone to apoptosis via decreased expression of survival factors and upregulation of cell death genes. These results suggest that lymphocytes are primed for elimination by interaction with metastatic tumor cells.
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Primary and metastatic tumors arising in nude mice were significantly different from those in wild-type animals. Differentiation of HNSCC from nude mice is shifted towards secretory genes compared to those arising in wild-type mice.
Comparison of gene expression in metastatic tumors in these two models indicated that metastatic SCC from nude mice may be more biologically aggressive than their counterparts in wild-type mice. However, these differences were not apparent in the number of lymph nodes containing metastatic tumor cells. Expression of cell cycle regulatory proteins examined by immunohistochemistry revealed important similarities with human HNSCC characterized in our previously published study (24) . Future studies will determine how these signaling pathways regulate metastatic phenotype and immune escape in HNSCC. ---------------------------------------------------------------------------------------------------- 
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